Meet the BaseLaunch Startups
Six of the BaseLaunch startups recently started Phase II. They received either grants up to 250,000 Swiss francs or gained free of charge access to BaseLaunch laboratory and office space at the Switzerland Innovation Park Basel Area. Hear what the startups, the BaseLaunch team and selection committee members experienced in the first year. Find out more about what makes BaseLaunch unique.
The BaseLaunch accelerator is now open for applications for the second cycle. Entrepreneurs with a healthcare based project or a game-changing innovation in diagnostics, medtech or related field at the pre-seed or seed funding stage are invited to submit their applications to the program.
Following the application deadline on 14 May, promising projects will be admitted to the accelerator program for a period of 15 months. In phase I, the startups will benefit from the support of industry experts, office- and laboratory space free of charge and access to healthcare partners. After three months, they will be invited to present their idea to the selection committee. They will determine which promising startups will proceed to Phase II that runs for one year.
BaseLaunch is backed by five industry leaders — Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer, Roche and Roivant Sciences. Other public and private partners such as KPMG and Vossius & Partner also support the initiative.
Share this article
You might also be interested in
Biotech companies in the Basel Area played a key role in the sector’s record performance in 2020. The latest Swiss...Read More
A new innovation campus is currently under construction in Allschwil. This will be known as Switzerland Innovation Park Basel Area...Read More
Ysios Capital joins the existing consortium of European investors to expand the Series A financing for Synendos Therapeutics. The Allschwil-based...Read More
Leading Swiss experts in immunology and virology have joined forces in the Basel-based startup RocketVax with the aim of developing...Read More
The Basel-based firm MTIP AG specializes in investments in HealthTech companies. A total of 130 million euros has already been...Read More